VolitionRX Q4 EPS $(0.11), Inline, Sales $243.97K Miss $450.00K Estimate
VolitionRX Q4 EPS $(0.11), Inline, Sales $243.97K Miss $450.00K Estimate
VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 15.38 percent increase over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $243.97 thousand which missed the analyst consensus estimate of $450.00 thousand by 45.78 percent. This is a 103.79 percent increase over sales of $119.72 thousand the same period last year.
VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 15.38 percent increase over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $243.97 thousand which missed the analyst consensus estimate of $450.00 thousand by 45.78 percent. This is a 103.79 percent increase over sales of $119.72 thousand the same period last year.
VolitionRX(美國證券交易所股票代碼:VNRX)公佈的季度虧損爲每股0.11美元,符合分析師的共識預期。這比去年同期每股虧損0.13美元(0.13美元)增長了15.38%。該公司公佈的季度銷售額爲243,970美元,比分析師普遍預期的45萬美元低45.78%。這比去年同期的119,720美元的銷售額增長了103.79%。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧